Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: Twenty-year follow up of the St. Jude Medical aortic valve prosthesis

Journal of Heart Valve Disease

Volumn 11, Issue SUPPL. 1, 2002, Pages

  Emery, Robert W ^a   Arom, Kit V ^a   Kshettry, Vibhu V ^a   Kroshus, Timothy J ^a   Von Rueden, Thomas J ^a   Kersten, Thomas E ^a   Lillehei, Theodore J ^a   Nicoloff, Demetre M ^a   Erickson, Carla A ^a  

^a Cardiac Surgical Associates Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DEATH; DRUG EFFICACY; DRUG SAFETY; ENDOCARDITIS; FEMALE; FOLLOW UP; GRAFT FAILURE; HEART HEMODYNAMICS; HEART VALVE BIOPROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INTERVIEW; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORTALITY; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SAINT JUDE HEART VALVE PROSTHESIS; SURVIVAL; TELEPHONE; THROMBOEMBOLISM;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSTHESIS FAILURE; SURVIVAL RATE; TIME FACTORS;

EID: 0036216911     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Partial and complete prosthesis in aortic insufficiency
2. Aortic valve decalcification
3. Anticoagulant-related complications in elderly patients with St. Jude mechanical valve prostheses
4. Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement
5. The St. Jude Medical bileaflet valve prosthesis. A 5-year experience
6. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve
7. Prognosis after aortic valve replacement with a bioprosthesis. Predictions based on meta-analysis and microsimulation
8. Long-term performance of heart valve prostheses
9. Bioprosthetic versus mechanical prostheses for aortic valve replacement in the elderly
10. Evolution of mechanical heart valves
11. Mechanical cardiac valvular prostheses
12. Clinical and hemodynamic results with the St. Jude Medical aortic valve prosthesis
13. Prospective randomized comparison of different mechanical aortic valves
14. Prosthetic heart valve performances long term follow-up
15. The Ross procedure: Current registry results
16. Discussion of Chaux AM
17. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis
18. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
19. Guidelines for prevention of thromboembolic events in valvular heart disease
20. Risk of thromboembolism with the aortic Carpentier-Edwards bioprosthesis
21. International Normalized Ratio self-Management after mechanical heart valve replacement: Is an early start advantageous?
22. Twenty-year comparison of tissue and mechanical valve replacement
23. Intracardiac thrombosis: Patient-related and device-related factors
24. Reoperation in biological and mechanical valve populations: Fate of the responsive patient
25. Guidelines for reporting morbidity and mortality after cardiac vascular operations
26. Event status of the Starr-Edwards aortic valve to 20 years: A benchmark for comparison
27. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves
28. Improvement of prognosis by home control in patients with life long anticoagulant therapy
29. Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulants
30. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, International Normalized Ratio adjusted, warfarin dose initially following heart valve replacement
31. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10-year follow-up of patients with St. Jude Medical Prosthesis
32. Excess mortality due to coronary artery disease after valve surgery. Secular trends in valvular regurgitation and effect of internal mammary artery bypass
33. Impact of mechanical heart valve prosthesis sound on patients' quality of life
34. Long-term follow-up of the St. Jude Medical prosthesis in pediatric patients
35. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients
36. Nineteen-millimeter aortic St. Jude Medical heart valve prosthesis: Up to sixteen years' follow-up
37. Comparative study of the hydrodynamic function of the size 19 mm and 21 mm St. Jude Medical hemodynamic plus bileaflet heart valves